Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:42 pm Purchase | 2021-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 10,232,973 7.200% | 2,012,973 (+24.49%) | Filing History |
| 2022-02-10 08:17 am Sale | 2021-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | The Vanguard Group | 12,007,076 8.500% | -237,312 (-1.94%) | Filing History |
| 2022-02-09 12:27 pm Purchase | 2021-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | ARK Investment Management LLC | 7,083,256 5.020% | 7,083,256 (New Position) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Ionis Pharmaceuticals, Inc. IONS | FMR LLC | 21,181,502 14.999% | 201,780 (+0.96%) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BlackRock Inc. BLK | 8,539,282 6.000% | -1,211,220 (-12.42%) | Filing History |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | T. Rowe Price Associates, Inc. | 13,114,967 9.300% | 13,114,967 (New Position) | Filing History |
| 2021-02-12 4:07 pm Purchase | 2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BB BIOTECH AG | 8,220,000 5.900% | 225,045 (+2.81%) | Filing History |
| 2021-02-10 11:03 am Purchase | 2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | The Vanguard Group | 12,244,388 8.760% | 277,996 (+2.32%) | Filing History |
| 2021-02-09 5:23 pm Sale | 2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | Clearbridge Investments LLC | 6,915,147 4.950% | -1,032,429 (-12.99%) | Filing History |
| 2021-02-08 10:25 am Sale | 2021-02-05 | 13G | Ionis Pharmaceuticals, Inc. IONS | FMR LLC | 20,979,722 14.999% | -144,340 (-0.68%) | Filing History |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS | BlackRock Inc. BLK | 9,750,502 7.000% | 1,348,113 (+16.04%) | Filing History |
| 2020-10-13 08:47 am Sale | 2020-10-10 | 13D | AKCEA THERAPEUTICS INC AKCA | IONIS PHARMACEUTICALS INC IONS | 1,000 100.000% | -77,093,682 (-100.00%) | Filing History |
| 2020-10-02 09:38 am Sale | 2020-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS | BAILLIE GIFFORD & CO | 4,920,843 3.520% | -3,869,182 (-44.02%) | Filing History |
| 2020-08-31 07:12 am Unchanged | 2020-08-30 | 13D | AKCEA THERAPEUTICS INC AKCA | IONIS PHARMACEUTICALS INC IONS | 77,094,682 75.900% | 0 (Unchanged) | Filing History |